Related references
Note: Only part of the references are listed.Outbreak of Colistin-Resistant, Carbapenem-Resistant Klebsiella pneumoniae in Metropolitan Detroit, Michigan
Dror Marchaim et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Adverse events associated with intravenous fosfomycin
Amelie Florent et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Meta-Analysis of a Possible Signal of Increased Mortality Associated with Cefepime Use Reply
Peter W. Kim et al.
CLINICAL INFECTIOUS DISEASES (2010)
The 10 x '20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020
David N. Gilbert et al.
CLINICAL INFECTIOUS DISEASES (2010)
Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation
A. Michalopoulos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia
Antonio T. Freire et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2010)
Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials
Matthew E. Falagas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study
Elad Goldberg et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Effectiveness and safety of colistin: prospective comparative cohort study
Mical Paul et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review
Matthew E. Falagas et al.
LANCET INFECTIOUS DISEASES (2010)
Resurgence of Colistin: A Review of Resistance, Toxicity, Pharmacodynamics, and Dosing
Lauren M. Lim et al.
PHARMACOTHERAPY (2010)
Antimicrobial Treatment and Clinical Outcomes of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia
Jeannie D. Chan et al.
JOURNAL OF INTENSIVE CARE MEDICINE (2010)
Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
D. Plachouras et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Nephrotoxicity Associated with Intravenous Colistin (Colistimethate Sodium) Treatment at a Tertiary Care Medical Center
Joshua D. Hartzell et al.
CLINICAL INFECTIOUS DISEASES (2009)
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Helen W. Boucher et al.
CLINICAL INFECTIOUS DISEASES (2009)
Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies
Matthew E. Falagas et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Nosocomial Outbreak of Infection With Pan-Drug-Resistant Acinetobacter baumannii in a Tertiary Care University Hospital
Raquel Valencia et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
Current Use for Old Antibacterial Agents: Polymyxins, Rifamycins, and Aminoglycosides
Luke F. Chen et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2009)
Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections
Nikos Roussos et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin
T. P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia
Alex Soriano et al.
CLINICAL INFECTIOUS DISEASES (2008)
Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline
Kara B. Anthony et al.
CLINICAL INFECTIOUS DISEASES (2008)
Fosfomycin: Use beyond urinary tract and gastrointestinal infections
Matthew E. Falagas et al.
CLINICAL INFECTIOUS DISEASES (2008)
Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection
Richard A. Proctor
CLINICAL INFECTIOUS DISEASES (2008)
Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: A prospective, open-label, uncontrolled study
Nikolaos Markou et al.
CLINICAL THERAPEUTICS (2008)
In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae
Anima Poudyal et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii
Jason J. Schafer et al.
PHARMACOTHERAPY (2007)
Acinetobacter baumannii bloodstream infection while receiving tigecycline: a cautionary report
Anton Y. Peleg et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections
Husnu Pullukcu et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii
Jian Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Jian Li et al.
LANCET INFECTIOUS DISEASES (2006)
Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections:: Case series and review of the literature
JJ Ruhe et al.
CLINICAL INFECTIOUS DISEASES (2005)
Colistin: The revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections
ME Falagas et al.
CLINICAL INFECTIOUS DISEASES (2005)
Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus
SA Grim et al.
PHARMACOTHERAPY (2005)
Evaluation of colistin as an agent against multi-resistant in Gram-negative bacteria
J Li et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics
BL Strom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Tetracyclines for treating multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia
GC Wood et al.
INTENSIVE CARE MEDICINE (2003)
In vitro activity of the aerosolized agents colistin and tobramycin and five intravenous agents against Pseudomonas aeruginosa isolated from cystic fibrosis patients in southwestern Germany
T Schülin
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Treatment of a complicated vancomycin-resistant enterococcal urinary tract infection with fosfomycin
NK Shrestha et al.
INFECTIOUS DISEASES IN CLINICAL PRACTICE (2000)